Anticancer Activity of the Choline Kinase Inhibitor PL48 Is Due to Selective Disruption of Choline Metabolism and Transport Systems in Cancer Cell Lines

  1. García-Molina, P.
  2. Sola-Leyva, A.
  3. Luque-Navarro, P.M.
  4. Laso, A.
  5. Ríos-Marco, P.
  6. Ríos, A.
  7. Lanari, D.
  8. Torretta, A.
  9. Parisini, E.
  10. López-Cara, L.C.
  11. Marco, C.
  12. Carrasco-Jiménez, M.P.
Journal:
Pharmaceutics

ISSN: 1999-4923

Year of publication: 2022

Volume: 14

Issue: 2

Type: Article

DOI: 10.3390/PHARMACEUTICS14020426 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus